investigation of short stature (height 89-5 cm, weight 15 1 kg). After overnight starvation she was given insulin (0 1 units/kg) intravenously and 35 minutes later developed nausea, sweating, and tachycardia and rapidly became unresponsive. Before her blood glucose concentration was measured she was given 50 ml of 50% dextrose intravenously with minimal response, and this was followed by a further 230 ml of 50% dextrose, 100 mg of hydrocortisone, and 1 mg of intramuscular glucagon. Her glucose concentration by dipstick testing was greater than 44 mmol/l one hour after she received insulin. At two hours she developed generalised convulsions, which were controlled with intravenous diazepam and phenytoin; her blood sugar concentration was raised at 130 mmol/l and plasma osmolality was 388 mmol/kg; she was given three bolus doses of intravenous insulin (0 13 units/kg each) with minimal effect on her blood glucose concentration. Within Should we rely less on pharmacological tests hormone secretion available, insulin induced hypo-in assessing children for treatment with growth glycaemia probably has the greatest potential for hormone? Perhaps more worrying is the use of such inducing neurological sequelae. However, this test has tests for the assessment of short normal children before the advantage of assessing reserves of adrenocortico-growth hormone treatment is tried. The selection of trophic hormone. In children suspected of hypo-patients and dose of growth hormone to be used should pituitarism it is prudent to use only half the usual dose not be determined by growth hormone response to a of insulin.' In case 2 the child was suspected to have pharmacological test but by the growth rate before hypopituitarism but was given a full dose of insulin. treatment and the condition being treated,'" as occurs Tests of insulin induced hypoglycaemia are not usually in countries such as Australia. Perhaps we should be recommended in children under 5 years. Glucagon more selective about the use of tests of pharmacological may be used to stimulate growth hormone secretion, as growth hormone secretion; certainly they are required in case 3, which additionally allows glucocorticoid to assess reserves of adrenocorticotrophic hormone secretion to be assessed and is potentially safer if but have limited application in discriminating which intravenous access is temporarily lost during the test. children respond to growth hormone treatment. An Excessively prolonged fasting before the test may appreciation of the course of action to be taken by diminish hepatic glycogen stores and contribute to an junior doctors during the management of severe excessive hypoglycaemic response.' In case 3 rebound hypoglycaemia, and the probable sequelae of excessive hypoglycaemia after glucagon was given was probably administration of hyperosmolar dextrose solutions, accentuated by the prolonged fast and vomiting. In may lead to a lower incidence of the development two cases the investigations were done in specialised of cerebral oedema. During pharmacological tests endocrine units and yet the children developed serious of growth hormone secretion greater vigilance and complications, highlighting the risks of these proce-improved resuscitation techniques need to be enterdures. These risks must be increased when the tests are tained if such tragedies are to be avoided in the future. done outside specialist units. No (2 ml/kg of 10% dextrose) and hydrocortisone (100 mg)
